Meta‐analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma

Summary Background The use of sirolimus (SRL)‐based immunosuppression protocols have been reported to reduce recurrence rates following liver transplantation (LT) for hepatocellular carcinoma (HCC), although this is still a matter for debate. Aim To undertake a systematic review and meta‐analysis of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2013-02, Vol.37 (4), p.411-419
Hauptverfasser:	Menon, K. V., Hakeem, A. R., Heaton, N. D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - surgery Digestive system Gastroenterology. Liver. Pancreas. Abdomen Graft Survival - drug effects Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Liver Neoplasms - diagnosis Liver Neoplasms - surgery Liver Transplantation Liver. Biliary tract. Portal circulation. Exocrine pancreas Medical sciences Neoplasm Recurrence, Local - prevention & control Pharmacology. Drug treatments Sirolimus - adverse effects Sirolimus - therapeutic use Survival Rate Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!